US20110060253A1 - Ultrasonic catheter with axial energy field - Google Patents

Abstract

A catheter system for delivering ultrasonic energy to a treatment site within a body lumen comprises a tubular body. The tubular body has a proximal end, a distal end and an energy delivery section positioned between the proximal end and the distal end. The catheter further comprises an inner core configured for insertion into the tubular body. The inner core comprises a first ultrasound radiating member axially separated from a second ultrasound radiating member by an intermediate flexible joint region. The inner core further comprises an electrically conductive portion configured to allow a voltage difference to be applied to at least one of the ultrasound radiating members. The inner core further comprises a high impedance cap positioned proximal to at least one of the ultrasound radiating members.

Description

PRIORITY APPLICATION
• This application is a divisional of U.S. application Ser. No. 10/751,843, filed 5 Jan. 2004, which claims the benefit of U.S. Provisional Application 60/438,141, filed 3 Jan. 2003, the entire disclosure of which is hereby incorporated by reference herein in its entirety.
FIELD OF THE INVENTION
• The present invention relates generally to ultrasonic catheters, and more specifically to ultrasonic catheters configured to deliver ultrasonic energy and a therapeutic compound to a treatment site.
BACKGROUND OF THE INVENTION
• Several medical applications use ultrasonic energy. For example, U.S. Pat. Nos. 4,821,740, 4,953,565 and 5,007,438 disclose the use of ultrasonic energy to enhance the effect of various therapeutic compounds. An ultrasonic catheter can be used to deliver ultrasonic energy and a therapeutic compound to a treatment site within a patient's body. Such an ultrasonic catheter typically includes an ultrasound assembly configured to generate ultrasonic energy and a fluid delivery lumen for delivering the therapeutic compound to the treatment site.
• As taught in U.S. Pat. No. 6,001,069, ultrasonic catheters can be used to treat human blood vessels that have become partially or completely occluded by plaque, thrombi, emboli or other substances that reduce the blood carrying capacity of the vessel. To remove or reduce the occlusion, the ultrasonic catheter is used to deliver solutions containing therapeutic compounds directly to the occlusion site. Ultrasonic energy generated by the ultrasound assembly enhances the effect of the therapeutic compounds. Such a device can be used in the treatment of diseases such as peripheral arterial occlusion or deep vein thrombosis. In such applications, the ultrasonic energy enhances treatment of the occlusion with therapeutic compounds such as urokinase, tissue plasminogen activator (“tPA”), recombinant tissue plasminogen activator (“rtPA”) and the like. Further information on enhancing the effect of a therapeutic compound using ultrasonic energy is provided in U.S. Pat. Nos. 5,318,014, 5,362,309, 5,474,531, 5,628,728, 6,001,069 and 6,210,356.
• Ultrasonic catheters can also be used to enhance gene therapy at a treatment site within the patient's body. For example, U.S. Pat. No. 6,135,976 discloses an ultrasonic catheter having one or more expandable sections capable of occluding a section of a body lumen, such as a blood vessel. A gene therapy composition is then delivered to the occluded portion of the vessel through the catheter fluid delivery lumen. Ultrasonic energy generated by the ultrasound assembly is applied to the occluded vessel, thereby enhancing the delivery of a genetic composition into the cells of the occluded vessel.
• Ultrasonic catheters can also be used to enhance delivery and activation of light activated drugs. For example, U.S. Pat. No. 6,176,842 discloses methods for using an ultrasonic catheter to treat biological tissues by delivering a light activated drug to the biological tissues and exposing the light activated drug to ultrasonic energy.
SUMMARY OF THE INVENTION
• In certain applications, it is desirable to project an axial ultrasonic energy field from the distal end of an ultrasonic catheter. Such a field, also referred to as a “forward-facing” field, is useful in many of the aforementioned applications, including clot dissolution and gene therapy. In particular, a high-power, forward-facing ultrasonic energy field is useful in the dissolution of an aged blood clot located in the coronary vasculature. Thus, a ultrasonic catheter that is capable of producing such an energy field, and that is also compatible with conventional cardiological practice, has been developed.
• In accordance with the foregoing, in an exemplary embodiment, a catheter system for delivering ultrasonic energy to a treatment site within a body lumen comprises a tubular body. The tubular body has a proximal end, a distal end and an energy delivery section positioned between the proximal end and the distal end. The catheter further comprises an inner core configured for insertion into the tubular body. The inner core comprises a first ultrasound radiating member axially separated from a second ultrasound radiating member by an intermediate flexible joint region. The inner core further comprises an electrically conductive portion configured to allow a voltage difference to be applied to at least one of the ultrasound radiating members. The inner core further comprises a high impedance cap positioned proximal to at least one of the ultrasound radiating members.
• In another exemplary embodiment, an ultrasound assembly comprises an elongate member having a proximal region and a distal region opposite the proximal region. A high impedance cap is positioned adjacent to the elongate member distal region. The ultrasound assembly further comprises an ultrasound radiating member positioned distal to the high impedance cap. The ultrasound radiating member is configured to generate a distribution of ultrasonic energy that has a greater density in a region axially distal to the ultrasound radiating member than in an annular region surrounding the ultrasound radiating member.
• In another exemplary embodiment, an apparatus comprises a tubular body having a proximal end, a distal end opposite the proximal end, and a treatment zone located between the distal end and the proximal end. The apparatus further comprises a plurality of fluid delivery lumens defined within the tubular body. The apparatus further comprises an inner core comprising a high impedance cap and at least one ultrasound radiating member positioned distal to the high impedance cap. The apparatus further comprises a plurality of cooling fluid channels defined between at least an inner surface of the tubular body and an outer surface of the inner core. Each cooling fluid channel is positioned generally radially between two fluid delivery lumens.
BRIEF DESCRIPTION OF THE DRAWINGS
• Exemplary embodiments of the ultrasonic catheter disclosed herein are illustrated in the accompanying drawings, which are for illustrative purposes only. The drawings comprise the following figures, in which like numerals indicate like parts.
• FIG. 1 is a schematic illustration of an ultrasonic catheter configured for insertion into large vessels of the human body.
• FIG. 2 is a cross-sectional view of the ultrasonic catheter ofFIG. 1 taken along line2-2.
• FIG. 3 is a schematic illustration of an elongate inner core configured to be positioned within the central lumen of the catheter illustrated inFIG. 2.
• FIG. 4 is a cross-sectional view of the elongate inner core ofFIG. 3 taken along line4-4.
• FIG. 5 is a schematic wiring diagram illustrating an exemplary technique for electrically connecting five groups of ultrasound radiating members to form an ultrasound assembly.
• FIG. 6 is a schematic wiring diagram illustrating an exemplary technique for electrically connecting one of the groups ofFIG. 5.
• FIG. 7A is a schematic illustration of the ultrasound assembly ofFIG. 5 housed within the inner core ofFIG. 4.
• FIG. 7B is a cross-sectional view of the ultrasound assembly ofFIG. 7A taken alongline7B-7B.
• FIG. 7C is a cross-sectional view of the ultrasound assembly ofFIG. 7A taken alongline7C-7C.
• FIG. 7D is a side view of an ultrasound assembly center wire twisted into a helical configuration.
• FIG. 8 illustrates the energy delivery section of the inner core ofFIG. 4 positioned within the energy delivery section of the tubular body ofFIG. 2.
• FIG. 9 illustrates a wiring diagram for connecting a plurality of temperature sensors with a common wire.
• FIG. 10 is a block diagram of a feedback control system for use with an ultrasonic catheter.
• FIG. 11A is a side view of a treatment site.
• FIG. 11B is a side view of the distal end of an ultrasonic catheter positioned at the treatment site ofFIG. 11A.
• FIG. 11C is a cross-sectional view of the distal end of the ultrasonic catheter ofFIG. 11B positioned at the treatment site before a treatment.
• FIG. 11D is a cross-sectional view of the distal end of the ultrasonic catheter ofFIG. 11C, wherein an inner core has been inserted into the tubular body to perform a treatment.
• FIG. 12 is a side view of an ultrasound catheter that is particularly well suited for insertion into small blood vessels of the human body.
• FIG. 13A is a cross-sectional view of a distal end of the ultrasound catheter ofFIG. 12.
• FIG. 13B is a cross-sectional view of the ultrasound catheter ofFIG. 12 taken throughline13B-13B ofFIG. 13A.
• FIG. 14 is a side view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field and including solid cylindrical ultrasound radiating members.
• FIG. 15 is a side view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field including comprising hollow cylindrical ultrasound radiating members.
• FIG. 16 is a side view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field and including a plurality of ultrasound radiating members.
• FIG. 17A is a cross-sectional view of a distal end of a catheter guidewire configured to produce a forward-facing ultrasonic energy field and comprising a plurality of ultrasound radiating members with substantially similar dimensions.
• FIG. 17B is a cross-sectional view of the catheter guidewire ofFIG. 17A taken alongline17B-17B.
• FIG. 18A is a cross-sectional view of a distal end of a catheter guidewire configured to produce a forward-facing ultrasonic energy field and comprising a plurality of ultrasound radiating members with varying dimensions.
• FIG. 18B is a cross-sectional view of the catheter guidewire ofFIG. 18A taken alongline18B-18B.
• FIG. 19A is a cross-sectional view of a distal end of a catheter guidewire configured to produce a forward-facing ultrasonic energy field and comprising a plurality of ultrasound radiating members with rectangular dimensions.
• FIG. 19B is a cross-sectional view of the catheter guidewire ofFIG. 19A taken alongline19B-19B.
• FIG. 20 is a side view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field and comprising a proximal end joint.
• FIG. 21 is a side view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field and comprising a flat distal horn.
• FIG. 22 is a cross-sectional view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field and comprising a blunt distal horn.
• FIG. 23 is a cross-sectional view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field and comprising a short pointed distal horn.
• FIG. 24 is a cross-sectional view of a distal end of an ultrasonic catheter configured to produce a forward-facing ultrasonic energy field and comprising a long pointed distal horn.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
• As described above, ultrasonic catheters capable of delivering multi-frequency ultrasonic energy and/or forward-facing ultrasonic energy fields to a treatment site within a patient's vasculature have been developed. Exemplary embodiments of these ultrasonic catheters, including exemplary methods of use, are described herein.
• The ultrasonic catheters described herein can be used to enhance the therapeutic effects of therapeutic compounds at a treatment site within a patient's body. As used herein, the term “therapeutic compound” refers broadly, without limitation, to a drug, medicament, dissolution compound, genetic material or any other substance capable of effecting physiological functions. Additionally, any mixture comprising any such substances is encompassed within this definition of “therapeutic compound”, as well as any substance falling within the ordinary meaning of these terms. The enhancement of the effects of therapeutic compounds using ultrasonic energy is described in U.S. Pat. Nos. 5,318,014, 5,362,309, 5,474,531, 5,628,728, 6,001,069, 6,096,000, 6,210,356 and 6,296,619. Specifically, for applications that treat human blood vessels that have become partially or completely occluded by plaque, thrombi, emboli or other substances that reduce the blood carrying capacity of a vessel, suitable therapeutic compounds include, but are not limited to, an aqueous solution containing heparin, urokinase, streptokinase, TPA and BB-10153 (manufactured by British Biotech, Oxford, UK).
• Certain features and aspects of the ultrasonic catheters disclosed herein may also find utility in applications where the ultrasonic energy itself provides a therapeutic effect. Examples of such therapeutic effects include preventing or reducing stenosis and/or restenosis; tissue ablation, abrasion or disruption; promoting temporary or permanent physiological changes in intracellular or intercellular structures; and rupturing micro-balloons or micro-bubbles for therapeutic compound delivery. Further information about such methods can be found in U.S. Pat. Nos. 5,269,291 and 5,431,663. Further information about using cavitation to produce biological effects can be found in U.S. Pat. RE36,939.
• The ultrasonic catheters described herein are configured for applying ultrasonic energy over a substantial length of a body lumen, such as, for example, the larger vessels located in the leg. However, it should be appreciated that certain features and aspects of the present invention may be applied to catheters configured to be inserted into the small cerebral vessels, in solid tissues, in duct systems and in body cavities. Such catheters are described in U.S. patent application Ser. No. 10/309,417, entitled “Small Vessel Ultrasound Catheter” and filed Dec. 3, 2002, the entire disclosure of which is hereby incorporated herein by reference. Additional embodiments that may be combined with certain features and aspects of the embodiments described herein are described in U.S. patent application Ser. No. 10/291,891, entitled “Ultrasound Assembly For Use With A Catheter” and filed Nov. 7, 2002, the entire disclosure of which is hereby incorporated herein by reference.
• For purposes of summarizing the invention and the advantages achieved over the prior art, certain objects and advantages of the invention have been described above. It is to be understood that not necessarily all such objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein.
• The embodiments disclosed herein are intended to be within the scope of the present invention. These and other embodiments should be apparent based on the following detailed description, which refers to the attached figures. The present invention is not limited to any particular disclosed embodiment, but is limited only by the claims set forth herein.
Overview of a Large Vessel Ultrasound Catheter.
• With initial reference toFIG. 1, anultrasonic catheter10 configured for use in the large vessels of a patient's anatomy is schematically illustrated. For example, theultrasonic catheter10 illustrated inFIG. 1 can be used to treat long segment peripheral arterial occlusions, such as those in the vascular system of the leg.
• As illustrated inFIG. 1, theultrasonic catheter10 generally comprises a multi-component, elongate flexibletubular body12 having aproximal region14 and adistal region15. Thetubular body12 includes a flexibleenergy delivery section18 and adistal exit port29 located in thedistal region15 of thecatheter10. Abackend hub33 is attached to theproximal region14 of thetubular body12, thebackend hub33 comprising aproximal access port31, aninlet port32 and a coolingfluid fitting46. Theproximal access port31 can be connected to controlcircuitry100 viacable45.
• Thetubular body12 and other components of thecatheter10 can be manufactured in accordance with any of a variety of techniques well known in the catheter manufacturing field. Suitable materials and dimensions can be readily selected based on the natural and anatomical dimensions of the treatment site and on the desired percutaneous access site.
• For example, in a preferred embodiment theproximal region14 of thetubular body12 comprises a material that has sufficient flexibility, kink resistance, rigidity and structural support to push theenergy delivery section18 through the patient's vasculature to a treatment site. Examples of such materials include, but are not limited to, extruded polytetrafluoroethylene (“PTFE”), polyethylenes (“PE”), polyamides and other similar materials. In certain embodiments, theproximal region14 of thetubular body12 is reinforced by braiding, mesh or other constructions to provide increased kink resistance and pushability. For example, nickel titanium or stainless steel wires can be placed along or incorporated into thetubular body12 to reduce kinking.
• In an embodiment configured for treating thrombus in the arteries of the leg, thetubular body12 has an outside diameter between about 0.060 inches and about 0.075 inches. In another embodiment, thetubular body12 has an outside diameter of about 0.071 inches. In certain embodiments, thetubular body12 has an axial length of approximately 105 centimeters, although other lengths may by appropriate for other applications.
• Theenergy delivery section18 of thetubular body12 preferably comprises a material that is thinner than the material comprising theproximal region14 of thetubular body12 or a material that has a greater acoustic transparency. Thinner materials generally have greater acoustic transparency than thicker materials. Suitable materials for theenergy delivery section18 include, but are not limited to, high or low density polyethylenes, urethanes, nylons, and the like. In certain modified embodiments, theenergy delivery section18 may be formed from the same material or a material of the same thickness as theproximal region14.
• In certain embodiments, thetubular body12 is divided into at least three sections of varying stiffness. The first section, which preferably includes theproximal region14, has a relatively higher stiffness. The second section, which is located in an intermediate region between theproximal region14 and thedistal region15 of thetubular body12, has a relatively lower stiffness. This configuration further facilitates movement and placement of thecatheter10. The third section, which preferably includes theenergy delivery section18, generally has a lower stiffness than the second section.
• FIG. 2 illustrates a cross section of thetubular body12 taken along line2-2 inFIG. 1. In the embodiment illustrated inFIG. 2, threefluid delivery lumens30 are incorporated into thetubular body12. In other embodiments, more or fewer fluid delivery lumens can be incorporated into thetubular body12. The arrangement of thefluid delivery lumens30 preferably provides a hollowcentral lumen51 passing through thetubular body12. The cross-section of thetubular body12, as illustrated inFIG. 2, is preferably substantially constant along the length of thecatheter10. Thus, in such embodiments, substantially the same cross-section is present in both theproximal region14 and thedistal region15 of thecatheter10, including theenergy delivery section18.
• In certain embodiments, thecentral lumen51 has a minimum diameter greater than about 0.030 inches. In another embodiment, thecentral lumen51 has a minimum diameter greater than about 0.037 inches. In one preferred embodiment, thefluid delivery lumens30 have dimensions of about 0.026 inches wide by about 0.0075 inches high, although other dimensions may be used in other applications.
• As described above, thecentral lumen51 preferably extends through the length of thetubular body12. As illustrated inFIG. 1, thecentral lumen51 preferably has adistal exit port29 and aproximal access port31. Theproximal access port31 forms part of thebackend hub33, which is attached to theproximal region14 of thecatheter10. Thebackend hub33 preferably further comprises coolingfluid fitting46, which is hydraulically connected to thecentral lumen51. Thebackend hub33 also preferably comprises a therapeuticcompound inlet port32, which is in hydraulic connection with thefluid delivery lumens30, and which can be hydraulically coupled to a source of therapeutic compound via a hub such as a Luer fitting.
• Thecentral lumen51 is configured to receive an elongateinner core34 of which a preferred embodiment is illustrated inFIG. 3. The elongateinner core34 preferably comprises aproximal region36 and adistal region38.Proximal hub37 is fitted on theinner core34 at one end of theproximal region36. One or more ultrasound radiating members are positioned within an inner coreenergy delivery section41 located within thedistal region38. The ultrasound radiating members form anultrasound assembly42, which will be described in greater detail below.
• As shown in the cross-section illustrated inFIG. 4, which is taken along lines4-4 inFIG. 3, theinner core34 preferably has a cylindrical shape, with an outer diameter that permits theinner core34 to be inserted into thecentral lumen51 of thetubular body12 via theproximal access port31. Suitable outer diameters of theinner core34 include, but are not limited to, about 0.010 inches to about 0.100 inches. In another embodiment, the outer diameter of theinner core34 is between about 0.020 inches and about 0.080 inches. In yet another embodiment, theinner core34 has an outer diameter of about 0.035 inches.
• Still referring toFIG. 4, in an exemplary embodiment, theinner core34 includes a cylindricalouter body35 that houses theultrasound assembly42. Theultrasound assembly42 comprises wiring and ultrasound radiating members, described in greater detail inFIGS. 5 through 7D, such that theultrasound assembly42 is capable of radiating ultrasonic energy from theenergy delivery section41 of theinner core34. Theultrasound assembly42 is electrically connected to thebackend hub33, where theinner core34 can be connected to controlcircuitry100 via cable45 (illustrated inFIG. 1). Preferably, an electrically insulatingpotting material43 fills theinner core34, surrounding theultrasound assembly42, thus preventing movement of theultrasound assembly42 with respect to theouter body35. In one embodiment, the thickness of theouter body35 is between about 0.0002 inches and 0.010 inches. In another embodiment, the thickness of theouter body35 is between about 0.0002 inches and 0.005 inches. In yet another embodiment, the thickness of theouter body35 is about 0.0005 inches.
• In an exemplary embodiment, theultrasound assembly42 comprises a plurality ofultrasound radiating members40 that are divided into one or more groups G1, G2, G3, . . . G(n). For example,FIGS. 5 and 6 are schematic wiring diagrams illustrating one technique for connecting five groups of ultrasound radiating members to form theultrasound assembly42. As illustrated inFIG. 5, theultrasound assembly42 comprises five groups G1, G2, G3, G4, G5 of ultrasound radiating members that are electrically connected to each other. The five groups are also electrically connected to thecontrol circuitry100.FIG. 6 is a schematic wiring diagram illustrating an example group G(n) which comprises a plurality ofultrasound radiating members40.
• As used herein, the terms “ultrasonic energy”, “ultrasound” and “ultrasonic” are broad terms, having their ordinary meanings, and further refer to, without limitation, mechanical energy transferred through longitudinal pressure or compression waves. Ultrasonic energy can be emitted as continuous or pulsed waves, depending on the requirements of a particular application. Additionally, ultrasonic energy can be emitted in waveforms having various shapes, such as sinusoidal waves, triangle waves, square waves, or other wave forms. Ultrasonic energy includes sound waves. In certain embodiments, the ultrasonic energy has a frequency between about 20 kHz and about 20 MHz. For example, in one embodiment, the waves have a frequency between about 500 kHz and about 20 MHz. In another embodiment, the waves have a frequency between about 1 MHz and about 3 MHz. In yet another embodiment, the waves have a frequency of about 2 MHz. The average acoustic power is between about 0.01 watts and 300 watts. In one embodiment, the average acoustic power is about 15 watts.
• As used herein, the term “ultrasound radiating member” refers to any apparatus capable of producing ultrasonic energy. For example, in one embodiment, an ultrasound radiating member comprises an ultrasonic transducer, which converts electrical energy into ultrasonic energy. A suitable example of an ultrasonic transducer for generating ultrasonic energy from electrical energy includes, but is not limited to, piezoelectric ceramic oscillators. Piezoelectric ceramics typically comprise a crystalline material, such as quartz, that change shape when an electrical current is applied to the material. This change in shape, made oscillatory by an oscillating driving signal, creates ultrasonic sound waves. In other embodiments, ultrasonic energy can be generated by an ultrasonic transducer that is remote from the ultrasound radiating member, and the ultrasonic energy can be transmitted, via, for example, a wire that is coupled to the ultrasound radiating member.
• Still referring toFIG. 5, thecontrol circuitry100 preferably comprises, among other things, avoltage source102. Thevoltage source102 comprises apositive terminal104 and anegative terminal106. Thenegative terminal106 is connected tocommon wire108, which connects the five groups G1-G5 ofultrasound radiating members40 in series. Thepositive terminal104 is connected to a plurality oflead wires110, which each connect to one of the five groups G1-G5 ofultrasound radiating members40. Thus, under this configuration, each of the five groups G1-G5, one of which is illustrated inFIG. 6, is connected to thepositive terminal104 via one of thelead wires110, and to thenegative terminal106 via thecommon wire108.
• Referring now toFIG. 6, each group G1-G5 comprises a plurality ofultrasound radiating members40. Each of theultrasound radiating members40 is electrically connected to thecommon wire108 and to thelead wire110 via one of twopositive contact wires112. Thus, when wired as illustrated, a constant voltage difference will be applied to eachultrasound radiating member40 in the group. Although the group illustrated inFIG. 6 comprises twelveultrasound radiating members40, one of ordinary skill in the art will recognize that more or fewerultrasound radiating members40 can be included in the group. Likewise, more or fewer than five groups can be included within theultrasound assembly42 illustrated inFIG. 5.
• FIG. 7A illustrates one preferred technique for arranging the components of the ultrasound assembly42 (as schematically illustrated inFIG. 5) into the inner core34 (as schematically illustrated inFIG. 4).FIG. 7A is a cross-sectional view of theultrasound assembly42 taken within group G1 inFIG. 5, as indicated by the presence of fourlead wires110. For example, if a cross-sectional view of theultrasound assembly42 was taken within group G4 inFIG. 5, only onelead wire110 would be present (that is, the one lead wire connecting group G5).
• Referring still toFIG. 7A, thecommon wire108 comprises an elongate, flat piece of electrically conductive material in electrical contact with a pair ofultrasound radiating members40. Each of theultrasound radiating members40 is also in electrical contact with apositive contact wire112. Because thecommon wire108 is connected to thenegative terminal106, and thepositive contact wire112 is connected to thepositive terminal104, a voltage difference can be created across eachultrasound radiating member40. Leadwires110 are preferably separated from the other components of theultrasound assembly42, thus preventing interference with the operation of theultrasound radiating members40 as described above. For example, in one preferred embodiment, theinner core34 is filled with an insulatingpotting material43, thus deterring unwanted electrical contact between the various components of theultrasound assembly42.
• FIGS. 7B and 7C illustrate cross sectional views of theinner core34 ofFIG. 7A taken alonglines7B-7B and7C-7C, respectively. As illustrated inFIG. 7B, theultrasound radiating members40 are mounted in pairs along thecommon wire108. Theultrasound radiating members40 are connected bypositive contact wires112, such that substantially the same voltage is applied to eachultrasound radiating member40. As illustrated inFIG. 7C, thecommon wire108 preferably comprises wide regions108W upon which theultrasound radiating members40 can be mounted, thus reducing the likelihood that the pairedultrasound radiating members40 will short together. In certain embodiments, outside the wide regions108W, thecommon wire108 may have a more conventional, rounded wire shape.
• In a modified embodiment, such as illustrated inFIG. 7D, thecommon wire108 is twisted to form a helical shape before being fixed within theinner core34. In such embodiments, theultrasound radiating members40 are oriented in a plurality of radial directions, thus enhancing the radial uniformity of the resulting ultrasonic energy field.
• The wiring arrangement described above can be modified to allow each group G1, G2, G3, G4, G5 to be independently powered. Specifically, by providing a separate power source within thecontrol system100 for each group, each group can be individually turned on or off, or can be driven with an individualized power. This provides the advantage of allowing the delivery of ultrasonic energy to be “turned off” in regions of the treatment site where treatment is complete, thus preventing deleterious or unnecessary ultrasonic energy to be applied to the patient.
• The embodiments described above, and illustrated inFIGS. 5 through 7, illustrate a plurality of ultrasound radiating members grouped spatially. That is, in such embodiments, all of the ultrasound radiating members within a certain group are positioned adjacent to each other, such that when a single group is activated, ultrasonic energy is delivered at a specific length of the ultrasound assembly. However, in modified embodiments, the ultrasound radiating members of a certain group may be spaced apart from each other, such that the ultrasound radiating members within a certain group are not positioned adjacent to each other. In such embodiments, when a single group is activated, ultrasonic energy can be delivered from a larger, spaced apart portion of the energy delivery section. Such modified embodiments may be advantageous in applications wherein it is desired to deliver a less focussed, more diffuse ultrasonic energy field to the treatment site.
• In an exemplary embodiment, theultrasound radiating members40 comprise rectangular lead zirconate titanate (“PZT”) ultrasound transducers that have dimensions of about 0.017 inches by about 0.010 inches by about 0.080 inches. In other embodiments, other configurations may be used. For example, disc-shapedultrasound radiating members40 can be used in other embodiments. In a preferred embodiment, thecommon wire108 comprises copper, and is about 0.005 inches thick, although other electrically conductive materials and other dimensions can be used in other embodiments. Leadwires110 are preferably 36-gauge electrical conductors, whilepositive contact wires112 are preferably 42-gauge electrical conductors. However, one of ordinary skill in the art will recognize that other wire gauges can be used in other embodiments.
• As described above, suitable frequencies for theultrasound radiating member40 include, but are not limited to, from about 20 kHz to about 20 MHz. In one embodiment, the frequency is between about 500 kHz and 20 MHz, and in another embodiment the frequency is between about 1 MHz and 3 MHz. In yet another embodiment, theultrasound radiating members40 are operated with a frequency of about 2 MHz.
• FIG. 8 illustrates theinner core34 positioned within thetubular body12. Details of theultrasound assembly42, provided inFIG. 7A, are omitted for clarity. As described above, theinner core34 can be slid within thecentral lumen51 of thetubular body12, thereby allowing the inner coreenergy delivery section41 to be positioned within the tubular bodyenergy delivery section18. For example, in a preferred embodiment, the materials comprising the inner coreenergy delivery section41, the tubular bodyenergy delivery section18, and thepotting material43 all comprise materials having a similar acoustic impedance, thereby minimizing ultrasonic energy losses across material interfaces.
• FIG. 8 further illustrates placement offluid delivery ports58 within the tubular bodyenergy delivery section18. As illustrated, holes or slits are formed from thefluid delivery lumen30 through thetubular body12, thereby permitting fluid flow from thefluid delivery lumen30 to the treatment site. Thus, a source of therapeutic compound coupled to theinlet port32 provides a hydraulic pressure which drives the therapeutic compound through thefluid delivery lumens30 and out thefluid delivery ports58.
• By evenly spacing thefluid delivery lumens30 around the circumference of thetubular body12, as illustrated inFIG. 8, a substantially even flow of therapeutic compound around the circumference of thetubular body12 can be achieved. In addition, the size, location and geometry of thefluid delivery ports58 can be selected to provide uniform fluid flow from thefluid delivery lumen30 to the treatment site. For example, in one embodiment,fluid delivery ports58 closer to the proximal region of theenergy delivery section18 have smaller diameters thanfluid delivery ports58 closer to the distal region of theenergy delivery section18, thereby allowing uniform delivery of fluid across the entireenergy delivery section18.
• For example, in one embodiment in which thefluid delivery ports58 have similar sizes along the length of thetubular body12, thefluid delivery ports58 have a diameter between about 0.0005 inches to about 0.0050 inches. In another embodiment in which the size of thefluid delivery ports58 changes along the length of thetubular body12, thefluid delivery ports58 have a diameter between about 0.001 inches to about 0.005 inches in the proximal region of theenergy delivery section18, and between about 0.005 inches to 0.0020 inches in the distal region of theenergy delivery section18. The increase in size between adjacentfluid delivery ports58 depends on the material comprising thetubular body12, and on the size of thefluid delivery lumen30. Thefluid delivery ports58 can be created in thetubular body12 by punching, drilling, burning or ablating (such as with a laser), or by any other suitable method. Therapeutic compound flow along the length of thetubular body12 can also be increased by increasing the density of thefluid delivery ports58 toward thedistal region15 of thetubular body12.
• It should be appreciated that it may be desirable to provide non-uniform fluid flow from thefluid delivery ports58 to the treatment site. In such embodiment, the size, location and geometry of thefluid delivery ports58 can be selected to provide such non-uniform fluid flow.
• Referring still toFIG. 8, placement of theinner core34 within thetubular body12 further defines coolingfluid lumens44. Coolingfluid lumens44 are formed between anouter surface39 of theinner core34 and aninner surface16 of thetubular body12. In certain embodiments, a cooling fluid is introduced through theproximal access port31 such that cooling fluid flow is produced through coolingfluid lumens44 and out distal exit port29 (seeFIG. 1). The coolingfluid lumens44 are preferably evenly spaced around the circumference of the tubular body12 (that is, at approximately 120° increments for a three-lumen configuration), thereby providing uniform cooling fluid flow over theinner core34. Such a configuration is desired to remove unwanted thermal energy at the treatment site. As will be explained below, the flow rate of the cooling fluid and the power to theultrasound assembly42 can be adjusted to maintain the temperature of the inner coreenergy delivery section41 within a desired range.
• In an exemplary embodiment, theinner core34 can be rotated or moved within thetubular body12. Specifically, movement of theinner core34 can be accomplished by maneuvering theproximal hub37 while holding thebackend hub33 stationary. The inner coreouter body35 is at least partially constructed from a material that provides enough structural support to permit movement of theinner core34 within thetubular body12 without kinking of thetubular body12. Additionally, the inner coreouter body35 preferably comprises a material having the ability to transmit torque. Suitable materials for the inner coreouter body35 include, but are not limited to, polyimides, polyesters, polyurethanes, thermoplastic elastomers and braided polyimides.
• In an exemplary embodiment, thefluid delivery lumens30 and the coolingfluid lumens44 are open at the distal end of thetubular body12, thereby allowing the therapeutic compound and the cooling fluid to pass into the patient's vasculature at the distal exit port. Or, if desired, thefluid delivery lumens30 can be selectively occluded at the distal end of thetubular body12, thereby providing additional hydraulic pressure to drive the therapeutic compound out of thefluid delivery ports58. In either configuration, theinner core34 can prevented from passing through the distal exit port by configuring theinner core34 to have a length that is less than the length of thetubular body12. In other embodiments, a protrusion is formed on theinner surface16 of thetubular body12 in thedistal region15, thereby preventing theinner core34 from passing through thedistal exit port29.
• In still other embodiments, thecatheter10 further comprises an occlusion device (not shown) positioned at thedistal exit port29. The occlusion device preferably has a reduced inner diameter that can accommodate a guidewire, but that is less than the outer diameter of thecentral lumen51. Thus, theinner core34 is prevented from extending through the occlusion device and out thedistal exit port29. For example, suitable inner diameters for the occlusion device include, but are not limited to, about 0.005 inches to about 0.050 inches. In other embodiments, the occlusion device has a closed end, thus preventing cooling fluid from leaving thecatheter10, and instead recirculating to theproximal region14 of thetubular body12. These and other cooling fluid flow configurations permit the power provided to theultrasound assembly42 to be increased in proportion to the cooling fluid flow rate. Additionally, certain cooling fluid flow configurations can reduce exposure of the patient's body to cooling fluids.
• In certain embodiments, as illustrated inFIG. 8, thetubular body12 further comprises one ormore temperature sensors20, which are preferably located within theenergy delivery section18. In such embodiments, theproximal region14 of thetubular body12 includes a temperature sensor lead wire (not shown) which can be incorporated into cable45 (illustrated inFIG. 1). Suitable temperature sensors include, but are not limited to, temperature sensing diodes, thermistors, thermocouples, resistance temperature detectors (“RTDs”) and fiber optic temperature sensors which use thermalchromic liquid crystals.Suitable temperature sensor20 geometries include, but are not limited to, a point, a patch or a stripe. Thetemperature sensors20 can be positioned within one or more of thefluid delivery lumens30, and/or within one or more of the coolingfluid lumens44.
• FIG. 9 illustrates one embodiment for electrically connecting thetemperature sensors20. In such embodiments, eachtemperature sensor20 is coupled to acommon wire61 and is associated with anindividual return wire62. Accordingly, n+1 wires can be used to independently sense the temperature at ndistinct temperature sensors20. The temperature at aparticular temperature sensor20 can be determined by closing aswitch64 to complete a circuit between that thermocouple'sindividual return wire62 and thecommon wire61. In embodiments wherein thetemperature sensors20 comprise thermocouples, the temperature can be calculated from the voltage in the circuit using, for example, asensing circuit63, which can be located within theexternal control circuitry100.
• In other embodiments, eachtemperature sensor20 is independently wired. In such embodiments, 2n wires pass through thetubular body12 to independently sense the temperature at nindependent temperature sensors20. In still other embodiments, the flexibility of thetubular body12 can be improved by using fiber optic basedtemperature sensors20. In such embodiments, flexibility can be improved because only n fiber optic members are used to sense the temperature at nindependent temperature sensors20.
• FIG. 10 illustrates one embodiment of afeedback control system68 that can be used with thecatheter10. Thefeedback control system68 can be integrated into the control system that is connected to theinner core34 via cable45 (as illustrated inFIG. 1). Thefeedback control system68 allows the temperature at eachtemperature sensor20 to be monitored and allows the output power of theenergy source70 to be adjusted accordingly. A physician can, if desired, override the closed or open loop system.
• Thefeedback control system68 preferably comprises anenergy source70,power circuits72 and apower calculation device74 that is coupled to theultrasound radiating members40. Atemperature measurement device76 is coupled to thetemperature sensors20 in thetubular body12. Aprocessing unit78 is coupled to thepower calculation device74, thepower circuits72 and a user interface anddisplay80.
• In operation, the temperature at eachtemperature sensor20 is determined by thetemperature measurement device76. Theprocessing unit78 receives each determined temperature from thetemperature measurement device76. The determined temperature can then be displayed to the user at the user interface anddisplay80.
• Theprocessing unit78 comprises logic for generating a temperature control signal. The temperature control signal is proportional to the difference between the measured temperature and a desired temperature. The desired temperature can be determined by the user (set at the user interface and display80) or can be preset within theprocessing unit78.
• The temperature control signal is received by thepower circuits72. Thepower circuits72 are preferably configured to adjust the power level, voltage, phase and/or current of the electrical energy supplied to theultrasound radiating members40 from theenergy source70. For example, when the temperature control signal is above a particular level, the power supplied to a particular group ofultrasound radiating members40 is preferably reduced in response to that temperature control signal. Similarly, when the temperature control signal is below a particular level, the power supplied to a particular group ofultrasound radiating members40 is preferably increased in response to that temperature control signal. After each power adjustment, theprocessing unit78 preferably monitors thetemperature sensors20 and produces another temperature control signal which is received by thepower circuits72.
• Theprocessing unit78 preferably further comprises safety control logic. The safety control logic detects when the temperature at atemperature sensor20 has exceeded a safety threshold. Theprocessing unit78 can then provide a temperature control signal which causes thepower circuits72 to stop the delivery of energy from theenergy source70 to that particular group ofultrasound radiating members40.
• Because, in certain embodiments, theultrasound radiating members40 are mobile relative to thetemperature sensors20, it can be unclear which group ofultrasound radiating members40 should have a power, voltage, phase and/or current level adjustment. Consequently, each group ofultrasound radiating member40 can be identically adjusted in certain embodiments. In a modified embodiment, the power, voltage, phase, and/or current supplied to each group ofultrasound radiating members40 is adjusted in response to thetemperature sensor20 which indicates the highest temperature. Making voltage, phase and/or current adjustments in response to the temperature sensed by thetemperature sensor20 indicating the highest temperature can reduce overheating of the treatment site.
• Theprocessing unit78 also receives a power signal from apower calculation device74. The power signal can be used to determine the power being received by each group ofultrasound radiating members40. The determined power can then be displayed to the user on the user interface anddisplay80.
• As described above, thefeedback control system68 can be configured to maintain tissue adjacent to theenergy delivery section18 below a desired temperature. For example, it is generally desirable to prevent tissue at a treatment site from increasing more than 6° C. As described above, theultrasound radiating members40 can be electrically connected such that each group ofultrasound radiating members40 generates an independent output. In certain embodiments, the output from the power circuit maintains a selected energy for each group ofultrasound radiating members40 for a selected length of time.
• Theprocessing unit78 can comprise a digital or analog controller, such as for example a computer with software. When theprocessing unit78 is a computer it can include a central processing unit (“CPU”) coupled through a system bus. As is well known in the art, the user interface anddisplay80 can comprise a mouse, a keyboard, a disk drive, a display monitor, a nonvolatile memory system, or any another. Also preferably coupled to the bus is a program memory and a data memory.
• In lieu of the series of power adjustments described above, a profile of the power to be delivered to each group ofultrasound radiating members40 can be incorporated into theprocessing unit78, such that a preset amount of ultrasonic energy to be delivered is pre-profiled. In such embodiments, the power delivered to each group ofultrasound radiating members40 can then be adjusted according to the preset profiles.
• Theultrasound radiating members40 can be operated in a pulsed mode. For example, in one embodiment, the time average power supplied to theultrasound radiating members40 is preferably between about 0.1 watts and 2 watts and more preferably between about 0.5 watts and 1.5 watts. In certain preferred embodiments, the time average power is approximately 0.6 watts or 1.2 watts. The duty cycle is preferably between about 1% and 50% and more preferably between about 5% and 25%. In certain preferred embodiments, the duty ratio is approximately 7.5% or 15%. The pulse averaged power is preferably between about 0.1 watts and 20 watts and more preferably between approximately 5 watts and 20 watts. In certain preferred embodiments, the pulse averaged power is approximately 8 watts and 16 watts. The amplitude during each pulse can be constant or varied.
• In one embodiment, the pulse repetition rate is preferably between about 5 Hz and 150 Hz and more preferably between about 10 Hz and 50 Hz. In certain preferred embodiments, the pulse repetition rate is approximately 30 Hz. The pulse duration is preferably between about 1 millisecond and 50 milliseconds and more preferably between about 1 millisecond and 25 milliseconds. In certain preferred embodiments, the pulse duration is approximately 2.5 milliseconds or 5 milliseconds.
• In one particular embodiment, theultrasound radiating members40 are operated at an average power of approximately 0.6 watts, a duty cycle of approximately 7.5%, a pulse repetition rate of 30 Hz, a pulse average electrical power of approximately 8 watts and a pulse duration of approximately 2.5 milliseconds.
• Theultrasound radiating members40 used with the electrical parameters described herein preferably has an acoustic efficiency greater than 50% and more preferably greater than 75%. Theultrasound radiating members40 can be formed a variety of shapes, such as, cylindrical (solid or hollow), flat, bar, triangular, and the like. The length of theultrasound radiating members40 is preferably between about 0.1 cm and about 0.5 cm. The thickness or diameter of theultrasound radiating members40 is preferably between about 0.02 cm and about 0.2 cm.
• FIGS. 11A through 11D illustrate an exemplary method for using theultrasonic catheter10. As illustrated inFIG. 11A, aguidewire84 similar to a guidewire used in typical angioplasty procedures is directed through a patient'svessels86 to atreatment site88 which includes aclot90. Theguidewire84 is directed through theclot90.Suitable vessels86 include, but are not limited to, the large periphery and the small cerebral blood vessels of the body. Additionally, as mentioned above, theultrasonic catheter10 also has utility in various imaging applications or in applications for treating and/or diagnosing other diseases in other body parts.
• As illustrated inFIG. 11B, thetubular body12 is slid over and is advanced along theguidewire84 using conventional over-the-guidewire techniques. Thetubular body12 is advanced until theenergy delivery section18 of thetubular body12 is positioned at theclot90. In certain embodiments, radiopaque markers (not shown) are positioned along theenergy delivery section18 of thetubular body12 to aid in the positioning of thetubular body12 within thetreatment site88.
• As illustrated inFIG. 11C, theguidewire84 is then withdrawn from thetubular body12 by pulling theguidewire84 from theproximal region14 of thecatheter10 while holding thetubular body12 stationary. This leaves thetubular body12 positioned at thetreatment site88.
• As illustrated inFIG. 11D, theinner core34 is then inserted into thetubular body12 until the ultrasound assembly is positioned at least partially within theenergy delivery section18 of thetubular body12. Once theinner core34 is properly positioned, theultrasound assembly42 is activated to deliver ultrasonic energy through theenergy delivery section18 to theclot90. As described above, in one embodiment, suitable ultrasonic energy is delivered with a frequency between about 20 kHz and about 20 MHz.
• In a certain embodiment, theultrasound assembly42 comprises sixtyultrasound radiating members40 spaced over a length between approximately 30 cm and 50 cm. In such embodiments, thecatheter10 can be used to treat anelongate clot90 without requiring movement of or repositioning of thecatheter10 during the treatment. However, it will be appreciated that in modified embodiments theinner core34 can be moved or rotated within thetubular body12 during the treatment. Such movement can be accomplished by maneuvering theproximal hub37 of theinner core34 while holding thebackend hub33 stationary.
• Referring again toFIG. 11D,arrows48 indicate that a cooling fluid flows through the coolingfluid lumen44 and out thedistal exit port29. Likewise,arrows49 indicate that a therapeutic compound flows through thefluid delivery lumen30 and out thefluid delivery ports58 to thetreatment site88.
• The cooling fluid can be delivered before, after, during or intermittently with the delivery of ultrasonic energy. Similarly, the therapeutic compound can be delivered before, after, during or intermittently with the delivery of ultrasonic energy. Consequently, the steps illustrated inFIGS. 11A through11D can be performed in a variety of different orders than as described above. In an exemplary embodiment, the therapeutic compound and ultrasonic energy are applied until theclot90 is partially or entirely dissolved. Once theclot90 has been dissolved to the desired degree, thetubular body12 and theinner core34 are withdrawn from thetreatment site88.
Overview of a Small Vessel Ultrasound Catheter
• Over the years, numerous types of ultrasound catheters have been proposed for various therapeutic purposes. However, none of the existing ultrasound catheters is well adapted for effective use within small blood vessels in the distal anatomy. For example, in one primary shortcoming, the region of the catheter on which the ultrasound assembly is located (typically along the distal end portion) is relatively rigid and therefore lacks the flexibility necessary for navigation through difficult regions of the distal anatomy. Furthermore, it has been found that it is very difficult to manufacture an ultrasound catheter having a sufficiently small diameter for use in small vessels while providing adequate pushability and torqueability. Still further, it has been found that the distal tip of an ultrasound catheter can easily damage the fragile vessels of the distal anatomy during advancement through the patient's vasculature.
• Accordingly, an urgent need exists for an improved ultrasound catheter that is capable of safely and effectively navigating small blood vessels. It is also desirable that such a device be capable of delivering adequate ultrasound energy to achieve the desired therapeutic purpose. It is also desirable that such a device be capable of accessing a treatment site in fragile distal vessels in a manner that is safe for the patient and that is not unduly cumbersome. The present invention addresses these needs.
• The advancement of an ultrasound catheter through a blood vessel to a treatment site can be difficult and dangerous, particularly when the treatment site is located within a small vessel in the distal region of a patient's vasculature. To reach the treatment site, it is often necessary to navigate a tortuous path around difficult bends and turns. During advancement through the vasculature, bending resistance along the distal end portion of the catheter can severely limit the ability of the catheter to make the necessary turns. Moreover, as the catheter is advanced, the distal tip of the catheter is often in contact with the inner wall of the blood vessel. The stiffness and rigidity of the distal tip of the catheter may lead to significant trauma or damage to the tissue along the inner wall of the blood vessel. As a result, advancement of an ultrasound catheter through small blood vessels can be extremely hazardous. Therefore, a need exists for an improved ultrasound catheter design that allows a physician to more easily navigate difficult turns in small blood vessels while minimizing trauma and/or damage along the inner walls of the blood vessels. To address this need, preferred embodiments of the present invention described herein provide an ultrasound catheter that is well suited for use in the treatment of small blood vessels or other body lumens having a small inner diameter.
• As used herein, the term “ultrasound energy” is a broad term and is used in its ordinary sense and means, without limitation, mechanical energy transferred through pressure or compression waves with a frequency greater than about 20 kHz. In one embodiment, the waves of the ultrasound energy have a frequency between about 500 kHz and 20 MHz and in another embodiment between about 1 MHz and 3 MHz. In yet another embodiment, the waves of the ultrasound energy have a frequency of about 3 MHz.
• As used herein, the term “catheter” is a broad term and is used in its ordinary sense and means, without limitation, an elongate flexible tube configured to be inserted into the body of a patient, such as, for example, a body cavity, duct or vessel.
• Referring now toFIGS. 12 through 13B, for purposes of illustration, preferred embodiments of the present invention provide anultrasound catheter1100 that is particularly well suited for use within small vessels of the distal anatomy, such as, for example, in the remote, small diameter, neurovasculature in the brain.
• As shown inFIGS. 12 and 13A, theultrasound catheter1100 generally comprises a multi-componenttubular body1102 having aproximal end1104 and adistal end1106. Thetubular body1102 and other components of thecatheter1100 can be manufactured in accordance with any of a variety of techniques well know in the catheter manufacturing field. As discussed in more detail below, suitable material dimensions can be readily selected taking into account the natural and anatomical dimensions of the treatment site and of the desired percutaneous access site.
• Preferably, thetubular body1102 can be divided into at least three sections of varying stiffness. The first section, which preferably includes theproximal end1104, is generally more stiff than a second section, which lies between theproximal end1104 and thedistal end1106 of the catheter. This arrangement facilitates the movement and placement of thecatheter1102 within small vessels. The third section, which includesultrasound radiating element1124, is generally stiffer than the second section due to the presence of theultrasound radiating element1124.
• In each of the embodiments described herein, the assembled ultrasound catheter preferably has sufficient structural integrity, or “pushability,” to permit the catheter to be advanced through a patient's vasculature to a treatment site without buckling or kinking. In addition, the catheter has the ability to transmit torque, such that the distal portion can be rotated into a desired orientation after insertion into a patient by applying torque to the proximal end.
• The elongate flexibletubular body1102 comprises an outer sheath1108 (seeFIG. 13A) that is positioned upon aninner core1110. In an embodiment particularly well suited for small vessels, theouter sheath1108 comprises extruded PEBAX, PTFE, PEEK, PE, polymides, braided polymides and/or other similar materials. The distal end portion of theouter sheath1108 is adapted for advancement through vessels having a very small diameter, such as those in the neurovasculature of the brain. Preferably, the distal end portion of theouter sheath1108 has an outer diameter between about 2 and 5 French. More preferably, the distal end portion of theouter sheath1108 has an outer diameter of about 2.8 French. In one preferred embodiment, theouter sheath1108 has an axial length of approximately 150 centimeters.
• In other embodiments, theouter sheath1108 can be formed from a braided tubing formed of, by way of example, high or low density polyethylenes, urethanes, nylons, and the like. Such an embodiment enhances the flexibility of thetubular body1102. For enhanced pushability and torqueability, theouter sheath1108 may be formed with a variable stiffness from the proximal to the distal end. To achieve this, a stiffening member may be included along the proximal end of thetubular body1102.
• Theinner core1110 defines, at least in part, adelivery lumen1112, which preferably extends longitudinally along the entire length of thecatheter1100. Thedelivery lumen1112 has adistal exit port1114 and aproximal access port1116. Referring again toFIG. 12, theproximal access port1116 is defined bydrug inlet port1117 of aback end hub1118, which is attached to theproximal end1104 of theother sheath1108. The illustratedback end hub1118 is preferably attached to acontrol box connector1120, the utility of which will be described in more detail below.
• Thedelivery lumen1112 is preferably configured to receive a guide wire (not shown). Preferably, the guidewire has a diameter of approximately 0.008 to 0.012 inches. More preferably, the guidewire has a diameter of about 0.010 inches. Theinner core1110 is preferably formed from polymide or a similar material which, in some embodiments, can be braided to increase the flexibility of thetubular body1102.
• With particular reference toFIGS. 13A and 13B, thedistal end1106 of thecatheter1102 preferably includes theultrasound radiating element1124. In the illustrated embodiment, theultrasound radiating element1124 comprises an ultrasound transducer, which converts, for example, electrical energy into ultrasound energy. In a modified embodiment, the ultrasound energy can be generated by an ultrasound transducer that is remote from theultrasound radiating element1124 and the ultrasound energy can be transmitted via, for example, a wire to theultrasound radiating element1124.
• In the embodiment illustrated inFIGS. 13A and 13B, theultrasound radiating element1124 is configured as a hollow cylinder. As such, theinner core1110 can extend through the lumen of theultrasound radiating element1124. Theultrasound radiating element1124 can be secured to theinner core1110 in any suitable manner, such as with an adhesive. A potting material may also be used to further secure the mounting of the ultrasound radiating element along the central core.
• In other embodiments, theultrasound radiating element1124 can be configured with a different shape. For example, the ultrasound radiating element may take the form of a solid rod, a disk, a solid rectangle or a thin block. Still further, theultrasound radiating element1124 may comprise a plurality of smaller ultrasound radiating elements. The illustrated arrangement is the generally preferred configuration because it provides for enhanced cooling of theultrasound radiating element1124. For example, in one preferred embodiment, a drug solution can be delivered through thedelivery lumen1112. As the drug solution passes through the lumen of the ultrasound radiating element, the drug solution may advantageously provide a heat sink for removing excess heat generated by theultrasound radiating element1124. In another embodiment, a return path can be formed in thespace1138 between the outer sheath and the inner core such that coolant from a coolant system can be directed through thespace1138.
• Theultrasound radiating element1124 is preferably selected to produce ultrasound energy in a frequency range that is well suited for the particular application. Suitable frequencies of ultrasound energy for the applications described herein include, but are not limited to, from about 20 kHz to about 20 MHz. In one embodiment, the frequency is between about 500 kHz and 20 MHz and in another embodiment from about 1 MHz and about 3 MHz. In yet another embodiment, the ultrasound energy has a frequency of about 3 MHz.
• As mentioned above, in the illustrated embodiment, ultrasound energy is generated from electrical power supplied to theultrasound radiating element1124. The electrical power can be supplied through thecontroller box connector1120, which is connected to apair wires1126,1128 that extend through thecatheter body1102. Theelectrical wires1126,1128 can be secured to theinner core1110, lay along theinner core1110 and/or extend freely in the space between theinner core1110 and theouter sheath1108. In the illustrated arrangement, thefirst wire1126 is connected to the hollow center of theultrasound radiating element1124 while thesecond wire1128 is connected to the outer periphery of theultrasound radiating element1124. Theultrasound radiating element1124 is preferably, but is not limited to, a transducer formed of a piezolectic ceramic oscillator or a similar material.
• With continued reference toFIGS. 13A and 13B, thedistal end1104 of thecatheter1100 preferably includes asleeve1130, which is generally positioned about theultrasound radiating element1124. Thesleeve1130 is preferably constructed from a material that readily transmits ultrasound energy. Suitable materials for thesleeve1130 include, but are not limited to, polyolefins, polyimides, polyester and other materials having a relatively low impedance to ultrasound energy. Low ultrasound impedance materials are materials that readily transmit ultrasound energy with minimal absorption of the ultrasound energy. The proximal end of thesleeve1130 can be attached to theouter sheath1108 with an adhesive1132. To improve the bonding of the adhesive1132 to theouter sheath1108, ashoulder1127 or notch may be formed in the outer sheath for attachment of the adhesive thereto. Preferably, theouter sheath1108 and thesleeve1130 have substantially the same outer diameter.
• In a similar manner, the distal end of thesleeve1130 can be attached to atip1134. In the illustrated arrangement, thetip1134 is also attached to the distal end of theinner core1110. Preferably, the tip is between about 0.5 and 4.0 millimeters in length. More preferably, the tip is about 2.0 millimeters in length. As illustrated, the tip is preferably rounded in shape to reduce trauma or damage to tissue along the inner wall of a blood vessel or other body structure during advancement toward a treatment site.
• With continued reference toFIG. 13B, thecatheter1100 preferably includes at least onetemperature sensor1136 along thedistal end1106. Thetemperature sensor1136 is preferably located on or near theultrasound radiating element1124. Suitable temperature sensors include but are not limited to, diodes, thermistors, thermocouples, resistance temperature detectors (RTDs), and fiber optic temperature sensors that used thermalchromic liquid crystals. The temperature sensor is preferably operatively connected to a control box (not shown) through a control wire, which extends through thecatheter body1102 andback end hub1118 and is operatively connected to a control box through thecontrol box connector1120. The control box preferably includes a feedback control system having the ability to monitor and control the power, voltage, current and phase supplied to the ultrasound radiating element. In this manner, the temperature along the relevant region of the catheter can be monitored and controlled for optimal performance. Details of the control box can be found in Assignee's co-pending provisional application entitled CONTROL POD FOR ULTRASONIC CATHETER, Application Ser. No. 60/336,630, filed Dec. 3, 2001, which is incorporated by reference in its entirety.
• In one exemplary application of theultrasound catheter1100 described above, the apparatus may be used to remove a thrombotic occlusion from a small blood vessel. In one preferred method of use, a free end of a guidewire is percutaneously inserted into the patient's vasculature at a suitable first puncture site. The guidewire is advanced through the vasculature toward a treatment site wherein the blood vessel is occluded by the thrombus. The guidewire wire is preferably then directed through the thrombus.
• After advancing the guidewire to the treatment site, thecatheter1100 is thereafter percutaneously inserted into the vasculature through the first puncture site and is advanced along the guidewire towards the treatment site using traditional over-the-guidewire techniques. Thecatheter1100 is advanced until thedistal end1106 of thecatheter1100 is positioned at or within the occlusion. Thedistal end1106 of thecatheter1100 may include one or more radiopaque markers (not shown) to aid in positioning thedistal end1106 within the treatment site.
• After placing the catheter, the guidewire can then be withdrawn from thedelivery lumen1112. A drug solution source (not shown), such as a syringe with a Luer fitting, is attached to thedrug inlet port1117 and thecontroller box connector1120 is connected to the control box. As such, the drug solution can be delivered through thedelivery lumen1112 and out thedistal access port1114 to the thrombus. Suitable drug solutions for treating a thrombus include, but are not limited to, an aqueous solution containing heparin, urokinase, streptokinase, and/or tissue plasminogen activator (TPA).
• Theultrasound radiating element1124 is activated to emit ultrasound energy from thedistal end1106 of thecatheter1100. As mentioned above, suitable frequencies for theultrasound radiating element1124 include, but are not limited to, from about 20 kHz to about 20 MHz. In one embodiment, the frequency is between about 500 kHz and 20 MHz and in another embodiment between about 1 MHz and 3 MHz. In yet another embodiment, the ultrasound energy is emitted at a frequency of about 3 MHz. The drug solution and ultrasound energy are applied until the thrombus is partially or entirely dissolved. Once the thrombus has been dissolved to the desired degree, thecatheter1100 is withdrawn from the treatment site.
• Overview of Ultrasonic Catheter with Axial Energy Field.
• As described above, in certain applications, it is desirable to project an axial (or “forward-facing”) ultrasonic energy field from the distal end of an ultrasonic catheter. For example, a high-power, forward-facing ultrasonic energy field is useful in the dissolution of aged blood clot located in the coronary vasculature.
• FIG. 14 illustrates a distal end of anultrasonic assembly2000 configured to produce a forward-facing ultrasonic energy field. Such anultrasonic assembly2000 can be used, for example, with certain of the above-described catheters by passing theultrasonic assembly2000 through the catheter central lumen.
• Theultrasonic assembly2000 illustrated inFIG. 14 comprises a series of substantially cylindricalultrasound radiating members2040 with flat ends, whereinelectrodes2100 are mounted on each of the ultrasound radiating member flat ends. Theultrasound radiating members2040 have a positive electrode2100(+) and a negative electrode2100(−). Theultrasonic assembly2000 further comprises aproximal cap2200 positioned adjacent the most proximal of theultrasound radiating members2040. Preferably, theproximal cap2200 has a relatively high acoustic impedance compared to the other materials surrounding the ultrasound radiating members, such as the tubular body and the patient's vasculature. In one embodiment, the proximal cap may be made of such materials as copper, stainless steel, or plated copper or stainless steel. Thecap2200 preferably has an impedance in the range of about 35-110 MRayle and more preferably about 40-50 MRayl. This configuration causes the radiated ultrasonic energy field to be substantially forward-facing (that is, in the distal direction) along the axis of theultrasonic assembly2000.
• In certain embodiments, as also illustrated inFIG. 14, the ultrasonic assembly further comprises one ormore joints2300 positioned between the individualultrasound radiating members2040. In this embodiment, thejoints2300 comprise an electrically insulating material to provide electrical insulation between successiveultrasound radiating members2040. In an exemplary embodiment, thejoints2300 comprise a material having acoustic transmission properties (such as, for example, acoustic impedance and acoustic transmission velocity) that closely match the acoustic properties of the adjacentultrasound radiating members2040, while still providing additional flexibility to theultrasonic assembly2000. Non limiting examples of such materials are epotek 377 and hysol 2039/3561. Such materials preferably have an impedance in the range of about 1-30 MRayl and more preferably about 2-8 MRayl.
• Although one orientation of electrode polarities is illustrated inFIG. 14, other electrode polarity orientations may be more appropriate in other embodiments. For example, a modified electrode polarity orientation is illustrated inFIG. 15. In this embodiment, thejoints2300 may be formed from an conductive material such that the twotransducers2040 form a “sandwich”, “paired” design, sharing a common electrode as described above with reference toFIG. 7B.
• FIG. 15 further illustrates that anultrasonic assembly2000 having ahollow core2110 can be used in modified embodiments. Such embodiments are advantageous in applications where something is to be passed through thehollow core2110 of theultrasonic assembly2000, such as for example, a guidewire, a cooling fluid or a therapeutic compound. Thehollow core2110 can be constructed in theultrasound radiating members2040, theelectrodes2100 and thejoints2300 using conventional techniques, such as for example, drilling or laser cutting. As mentioned above, in this embodiment, the joint2300 may be made a conductive material. However, the hollow ultrasound radiating members illustrated inFIG. 15 can be used with the electrical configuration illustrated inFIG. 14. Additional information relating to ultrasound radiating members with hollow cores can be found in U.S. patent application Ser. No. 10/684,845, filed 14 Oct. 2003, the entire contents of which are hereby incorporated herein by reference.
• FIG. 16 illustrates that theultrasonic assembly2000 illustrated inFIGS. 14 and 15 can be expanded to include more than twoultrasound radiating members2040. This configuration facilitates formation of a forward-facing, or axial, energy field. In particular, ultrasonic energy generated by the ultrasound radiating members is focussed in the distal direction due to the presence of thehigh impedance cap2200 at the proximal end of theultrasound radiating members2040. In such embodiments, the ultrasonic energy density in a region axially distal to theassembly2000 is greater than the ultrasonic energy density in an annular region surrounding theassembly2000.
• Still referring to the exemplary embodiment illustrated inFIG. 16,joints2300 are preferably positioned between each of theultrasound radiating members2040, thereby maintaining the overall flexibility of theultrasonic assembly2000. In addition, in an exemplary embodiment, electrodes (not shown for clarity) can be positioned on each flat end of each ultrasound radiating member, with adjacent electrodes separated byjoints2300. Thus, in certain embodiments,joints2300 may comprise an electrically insulating material such asFIG. 14 or an electrically conducting material as inFIG. 15.
• The ultrasonic assemblies described herein can be incorporated for use with both catheters and guidewires. For example,FIG. 17A illustrates a guidewire-mounted ultrasonic assembly configured to produce a forward-facing ultrasonic energy field. Specifically, a plurality of cylindricalultrasound radiating members2040 are mounted to thedistal tip2410 of aguidewire2420. In an exemplary embodiment, thedistal tip2410 of theguidewire2420 comprises a material with relatively high acoustic impedance (e.g., the high impedance materials described above), thus producing a substantially forward-facing ultrasonic energy field. Electrodes and joints (both not shown for clarity) can be positioned between theultrasound radiating members2040 as described above, and as required for particular applications. In such embodiments, the joints may be conductive or insulating depending on the desired electrical arrangement. In the embodiment illustrated inFIG. 17A, theultrasound radiating members2040 have substantially similar dimensions, as can be seen in the cross-sectional view of the end of the ultrasonic assembly shown inFIG. 17B.
• FIG. 18A illustrates a modified embodiment of a guidewire-mounted ultrasonic assembly configured to produce a forward-facing ultrasonic energy field. In such embodiments, theultrasound radiating members2040 have decreasing dimensions toward the distal end of the assembly, thus providing a tapered tip.FIG. 18B is a cross-sectional view of the catheter guidewire ofFIG. 18A taken alongline18B-18B. A tapered tip provides increased guidewire maneuverability, which is advantageous in certain applications. From this discussion, one of ordinary skill in the art will recognize that, in general, theguidewire2420 need not have dimensions that match the dimensions of theultrasound radiating members2040. Again, as with the previous embodiments, the joints may be conductive or insulating.
• FIG. 19A illustrates a modified embodiment of a guidewire-mounted ultrasonic assembly configured to produce a forward-facing ultrasonic energy field. In such embodiments, theultrasound radiating members2040 have rectangular dimensions, thus providing a square tip. In addition,FIG. 19A illustrates that, in such rectangular-dimensioned ultrasound assemblies, theelectrodes2100 can be positioned generally perpendicular to thejoints2030.FIG. 19B is a cross-sectional view of the catheter guidewire ofFIG. 19A taken alongline19B-19B. In this configuration, a ultrasound radiating member group comprises two ultrasound radiating members separated by anelectrode2100. A plurality of ultrasound radiating member groups can be axially spaced along theguidewire2420, with the groups being separated by thejoints2300.
• Rectangular ultrasound radiating members can provide a reduced fabrication cost, which is advantageous in certain applications. In other embodiments, ultrasound radiating members having other cross-sectional shapes, such as other polygons or ovals, can be mounted to thedistal tip2410 of theguidewire2420.
• As described above, the various ultrasound assemblies illustrated inFIGS. 17A through 19B can be used with catheters as well as guidewires. Specifically, the ultrasound assemblies described above can be mounted directly on a catheter, or can be mounted on an inner core configured to be passed through a catheter central lumen. By positioning a high acoustic impedance material adjacent to the most proximal ultrasound radiating member, a substantially forward-facing ultrasonic energy field can be produced.
• By manipulating the dimensions of the ultrasound radiating members comprising the ultrasonic assemblies described above, the resonant frequency of a particular ultrasonic assembly can be determined. Likewise, the resonant frequency of an ultrasonic assembly may be dependent on other factors, such as number of ultrasound radiating members. Thus, if a particular application requires a particular frequency of ultrasonic energy to be applied to the treatment site, the dimensions and number of ultrasound radiating members present within the ultrasonic assembly can be adjusted accordingly.
• In certain embodiments, such as illustrated inFIG. 20, a joint2300 is positioned between the most proximalultrasound radiating member2040′ and the relatively highacoustic impedance material2200. Such a configuration further increases flexibility, and therefore maneuverability, of the ultrasonic assembly. Again, the joints may be conductive or insulating depending upon the desired electrical configuration.
• In modified embodiments, such as illustrated inFIG. 21, ahorn2250 comprising an acoustically matched material (e.g., a material having a similar acoustic property as the transducer) mounted to the distal tip of the catheter or guidewire. e.g., stainless steel and titanium Such a configuration would further enhance the production of a forward-facing ultrasonic energy field from the ultrasonic assembly. The characteristics of the ultrasonic energy field produced can be further manipulated by adjusting the dimensions and shape of thehorn2250. For example, appropriate shapes forhorn2250 include flat (illustrated inFIG. 21), blunt (illustrated inFIG. 22), short pointed (illustrated inFIG. 23) and long pointed (illustrated inFIG. 24). The addition of thehorn2250 is particularly advantageous with the sandwich type configurations described with reference, for example, toFIG. 15.
• The various embodiments of the ultrasonic assemblies described herein offer several advantages. For example, the ultrasonic assemblies described herein can be operated at a reduced operational frequency as compared to conventional ultrasonic assemblies having a comparable size. Lower operational frequencies advantageously increase the therapeutic effect of the ultrasonic energy. Additionally, the ultrasonic assemblies described herein can be operated with increased power output and widened forward dispersion as compared to conventional ultrasonic assemblies. Furthermore, the highly directional nature of the ultrasonic energy field produced by the ultrasonic assemblies described herein is advantageous in certain applications that require a targeted or focussed delivery of ultrasonic energy to the treatment site.
SCOPE OF THE INVENTION
• While the foregoing detailed description discloses several embodiments of the present invention, it should be understood that this disclosure is illustrative only and is not limiting of the present invention. It should be appreciated that the specific configurations and operations disclosed can differ from those described above, and that the methods described herein can be used in contexts other than treatment of vascular diseases.

Claims (8)

I claim:

1. An apparatus comprising:

a tubular body having a proximal end, a distal end opposite the proximal end, and a treatment zone located between the distal end and the proximal end;

a plurality of fluid delivery lumens defined within the tubular body;

an inner core comprising a high impedance member and at least one ultrasound radiating member positioned distal to the high impedance member; and

a plurality of cooling fluid channels defined between at least an inner surface of the tubular body and an outer surface of the inner core, each cooling fluid channel being positioned generally radially between two fluid delivery lumens.

2. The apparatus ofclaim 1, wherein the inner core further comprises a low impedance horn positioned distal to the ultrasound radiating member.

3. The apparatus ofclaim 1, wherein the inner core further comprises an electrically conductive portion configured to allow a voltage difference to be applied to the ultrasound radiating member.

4. The apparatus ofclaim 1, wherein the inner core comprises a plurality of ultrasound radiating members having a rectangular configuration.

5. The apparatus ofclaim 1, wherein the inner core comprises a plurality of ultrasound radiating members having a cylindrical configuration.

6. The apparatus ofclaim 1, wherein the inner core comprises a plurality of ultrasound radiating members having a cylindrical configuration, at least two of the cylindrical ultrasound radiating members having a different diameter.

7. The apparatus ofclaim 1, wherein the inner core comprises a plurality of ultrasound radiating members that are separated by an intermediate flexible joint region.

8. The apparatus ofclaim 1, wherein the inner core comprises a plurality of ultrasound radiating members that are separated by an intermediate flexible joint region that is electrically insulating.

Images